| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Andrea Hernández-Sánchez, Lidia Parra-Sánchez, Marisol Montolio, Lola Rueda-Ruzafa, Lucía Ortiz-Comino, María Del Mar Sánchez-Joy. Family Involvement and at-Home Physical Therapy on Duchenne Muscular Dystrophy: A Randomized Controlled Trial. Pediatric neurology. vol 152. 2024-01-07. PMID:38184986. |
duchenne muscular dystrophy (dmd) is a genetic condition that causes muscle weakness and begins in early childhood. |
2024-01-07 |
2024-01-10 |
Not clear |
| Abdelbaset Mohamed Elasbali, Waleed Abu Al-Soud, Mohd Adnan, Hassan H Alhassan, Taj Mohammad, Md Imtaiyaz Hassa. Discovering Promising Biomarkers and Therapeutic Targets for Duchenne Muscular Dystrophy: a Multiomics Meta-Analysis Approach. Molecular neurobiology. 2024-01-02. PMID:38165583. |
duchenne muscular dystrophy (dmd) is a genetic disorder that causes muscle weakness and degeneration. |
2024-01-02 |
2024-01-10 |
Not clear |
| Giorgia Coratti, Marika Pane, Claudia Brogna, Adele D'Amico, Elena Pegoraro, Luca Bello, Valeria A Sansone, Emilio Albamonte, Elisabetta Ferraroli, Elena Stacy Mazzone, Lavinia Fanelli, Sonia Messina, Maria Sframeli, Michela Catteruccia, Gianpaolo Cicala, Anna Capasso, Martina Ricci, Silvia Frosini, Giacomo De Luca, Enrica Rolle, Roberto De Sanctis, Nicola Forcina, Giulia Norcia, Luigia Passamano, Marianna Scutifero, Alice Gardani, Antonella Pini, Giulia Monaco, Maria Grazia D'Angelo, Daniela Leone, Riccardo Zanin, Gian Luca Vita, Chiara Panicucci, Claudio Bruno, Tiziana Mongini, Federica Ricci, Angela Berardinelli, Roberta Battini, Riccardo Masson, Giovanni Baranello, Claudia Dosi, Enrico Bertini, Vincenzo Nigro, Luisa Politano, Eugenio Mercur. Gain and loss of upper limb abilities in Duchenne muscular dystrophy patients: A 24-month study. Neuromuscular disorders : NMD. vol 34. 2023-12-29. PMID:38157655. |
duchenne muscular dystrophy (dmd) is a neuromuscular condition characterized by muscle weakness. |
2023-12-29 |
2024-01-05 |
Not clear |
| Victoria Brown, Elizabeth Merikle, Kelly Johnston, Katherine Gooch, Ivana Audhya, Linda Lowe. A qualitative study to understand the Duchenne muscular dystrophy experience from the parent/patient perspective. Journal of patient-reported outcomes. vol 7. issue 1. 2023-12-12. PMID:38085412. |
duchenne muscular dystrophy (dmd) is a rare, severe, fatal neuromuscular disease characterized by progressive atrophy and muscle weakness, resulting in loss of ambulation, decreased upper body function, and impaired cardiorespiratory function. |
2023-12-12 |
2023-12-17 |
Not clear |
| Kuan-Wen Wu, Cheng-Hao Yu, Tse-Hua Huang, Shiuan-Huei Lu, Yu-Lin Tsai, Ting-Ming Wang, Tung-Wu L. Children with Duchenne muscular dystrophy display specific kinematic strategies during obstacle-crossing. Scientific reports. vol 13. issue 1. 2023-10-10. PMID:37816796. |
duchenne muscular dystrophy (dmd) is a genetic disease characterized by progressive muscle weakness with increased neuromechanical challenge and fall risks, especially during obstructed locomotion. |
2023-10-10 |
2023-10-15 |
Not clear |
| Kyriaki Kekou, Maria Svingou, Nikos Vogiatzakis, Evangelia Nitsa, Danai Veltra, Nikolaos M Marinakis, Faidon-Nikolaos Tilemis, Maria Tzetis, Anastasios Mitrakos, Charalambia Tsaroucha, Nicoletta Selenti, Giorgos-Konstantinos Papadimas, Constantinos Papadopoulos, Joanne Traeger-Synodinos, Hanns Lochmuller, Christalena Sofocleou. Retrospective analysis of persistent HyperCKemia with or without muscle weakness in a case series from Greece highlights vast heterogeneous DMD gene variants. Expert review of molecular diagnostics. 2023-09-27. PMID:37754746. |
retrospective analysis of persistent hyperckemia with or without muscle weakness in a case series from greece highlights vast heterogeneous dmd gene variants. |
2023-09-27 |
2023-10-07 |
Not clear |
| Marcelo Dos Santos Voltani Lorena, Estela Kato Dos Santos, Renato Ferretti, G A Nagana Gowda, Guy L Odom, Jeffrey S Chamberlain, Cintia Yuri Matsumur. Biomarkers for Duchenne muscular dystrophy progression: impact of age in the mdx tongue spared muscle. Skeletal muscle. vol 13. issue 1. 2023-09-13. PMID:37705069. |
dmd results in muscle weakness, loss of ambulation, and death at an early age. |
2023-09-13 |
2023-10-07 |
mouse |
| Abdolvahab Ebrahimpour Gorji, Piotr Ostaszewski, Kaja Urbańska, Tomasz Sadkowsk. Does β-Hydroxy-β-Methylbutyrate Have Any Potential to Support the Treatment of Duchenne Muscular Dystrophy in Humans and Animals? Biomedicines. vol 11. issue 8. 2023-08-26. PMID:37626825. |
duchenne muscular dystrophy (dmd) is an x-linked neuromuscular condition causing progressive muscle weakness and premature death. |
2023-08-26 |
2023-09-07 |
mouse |
| Qiliang Xiong, Yuan Liu, Jieyi Mo, Yuxia Chen, Lianghong Zhang, Zhongyan Xia, Chen Yi, Shaofeng Jiang, Nong Xia. Gait asymmetry in children with Duchenne muscular dystrophy: evaluated through kinematic synergies and muscle synergies of lower limbs. Biomedical engineering online. vol 22. issue 1. 2023-07-31. PMID:37525241. |
in the context of duchenne muscular dystrophy (dmd), a disease characterized by progressive muscle weakness and joint contractures, previous studies have generally assumed symmetrical behavior of the lower limbs during gait. |
2023-07-31 |
2023-08-14 |
Not clear |
| Boel De Paep. What Nutraceuticals Can Do for Duchenne Muscular Dystrophy: Lessons Learned from Amino Acid Supplementation in Mouse Models. Biomedicines. vol 11. issue 7. 2023-07-29. PMID:37509672. |
duchenne muscular dystrophy (dmd), the severest form of muscular dystrophy, is characterized by progressive muscle weakness with fatal outcomes most often before the fourth decade of life. |
2023-07-29 |
2023-08-14 |
mouse |
| Tetsushi Yamamoto, Yoshinori Nambu, Ryosuke Bo, Shotaro Morichi, Misato Yanagiya, Masafumi Matsuo, Hiroyuki Awan. Electrocardiographic R wave amplitude in V6 lead as a predictive marker of cardiac dysfunction in Duchenne muscular dystrophy. Journal of cardiology. 2023-07-22. PMID:37481234. |
duchenne muscular dystrophy (dmd) is an inherited muscular disease characterized by progressive and fatal muscle weakness. |
2023-07-22 |
2023-08-14 |
Not clear |
| Jeehyun Lee, Nia O Myrie, Gun-Jae Jeong, Woojin M Han, Young C Jang, Andrés J García, Stanislav Emeliano. In vivo shear wave elasticity imaging for assessment of diaphragm function in muscular dystrophy. Acta biomaterialia. 2023-07-15. PMID:37453552. |
statement of significance: in dmd patients, muscles experience cycles of regeneration and degeneration that contribute to chronic inflammation and muscle weakness. |
2023-07-15 |
2023-08-14 |
mouse |
| Dylan Moutachi, Mégane Lemaitre, Clément Delacroix, Onnik Agbulut, Denis Furling, Arnaud Ferr. Valproic acid reduces muscle susceptibility to contraction-induced functional loss but increases weakness in two murine models of Duchenne muscular dystrophy. Clinical and experimental pharmacology & physiology. 2023-06-29. PMID:37381823. |
the results of our study indicated that vpa in both murine dmd models reduced the susceptibility to contraction-induced functional loss but increased muscle weakness. |
2023-06-29 |
2023-08-14 |
mouse |
| Adelina Balidemaj, Parmis Parsamanesh, Mykhailo Vysochy. Exploring the Dynamics of Caring for a Child With a Terminal Illness of Duchenne Muscular Dystrophy (DMD) and Its Copious Components on the Caregivers. Cureus. vol 15. issue 5. 2023-06-29. PMID:37384074. |
duchenne muscular dystrophy (dmd) is an inherited disorder that results in increasing muscle degeneration and muscle weakness because of a mutation in the dystrophin protein. |
2023-06-29 |
2023-08-14 |
human |
| Thomas G George, Laurin M Hanft, Maike Krenz, Timothy L Domeier, Kerry S McDonal. Dystrophic cardiomyopathy: role of the cardiac myofilaments. Frontiers in physiology. vol 14. 2023-06-27. PMID:37362434. |
patients with dmd present with progressive skeletal muscle weakness and, because of treatment advances, a cardiac component of the disease (i.e., dystrophic cardiomyopathy) has been unmasked later in disease progression. |
2023-06-27 |
2023-08-14 |
mouse |
| Norma P Tavakoli, Dorota Gruber, Niki Armstrong, Wendy K Chung, Breanne Maloney, Sunju Park, Julia Wynn, Carrie Koval-Burt, Lorraine Verdade, David H Tegay, Lilian L Cohen, Natasha Shapiro, Annie Kennedy, Garey Noritz, Emma Ciafaloni, Barry Weinberger, Marty Ellington, Charles Schleien, Regina Spinazzola, Sunil Sood, Amy Brower, Michele Lloyd-Puryear, Michele Caggan. Newborn screening for Duchenne muscular dystrophy: A two-year pilot study. Annals of clinical and translational neurology. 2023-06-23. PMID:37350320. |
duchenne muscular dystrophy (dmd) is an x-linked disorder resulting in progressive muscle weakness and atrophy, cardiomyopathy, and in late stages, cardiorespiratory impairment, and death. |
2023-06-23 |
2023-08-14 |
Not clear |
| Kasun Kodippili, Michael A Rudnick. Satellite cell contribution to disease pathology in Duchenne muscular dystrophy. Frontiers in physiology. vol 14. 2023-06-16. PMID:37324396. |
progressive muscle weakness and degeneration characterize duchenne muscular dystrophy (dmd), a lethal, x-linked neuromuscular disorder that affects 1 in 5,000 boys. |
2023-06-16 |
2023-08-14 |
Not clear |
| Jae-Sung You, Yongdeok Kim, Soohyun Lee, Rashid Bashir, Jie Che. RhoA/ROCK signalling activated by ARHGEF3 promotes muscle weakness via autophagy in dystrophic mdx mice. Journal of cachexia, sarcopenia and muscle. 2023-06-13. PMID:37311604. |
duchenne muscular dystrophy (dmd), caused by dystrophin deficiency, leads to progressive and fatal muscle weakness through yet-to-be-fully deciphered molecular perturbations. |
2023-06-13 |
2023-08-14 |
mouse |
| Krzysztof Zabłocki, Dariusz C Góreck. The Role of P2X7 Purinoceptors in the Pathogenesis and Treatment of Muscular Dystrophies. International journal of molecular sciences. vol 24. issue 11. 2023-06-11. PMID:37298386. |
the most severe, common types are duchenne muscular dystrophy (dmd) and limb-girdle sarcoglycanopathy, which cause advancing muscle weakness and wasting. |
2023-06-11 |
2023-08-14 |
mouse |
| Audrey S Chan, Justin P Hardee, Martha Blank, Ellie H-J Cho, Narelle E McGregor, Natalie A Sims, Gordon S Lync. Increasing muscle contractility through low-frequency stimulation alters tibial bone geometry and reduces bone strength in Journal of applied physiology (Bethesda, Md. : 1985). 2023-06-01. PMID:37262103. |
as dmd patients also develop bone fragility because of muscle weakness and immobilization, better understanding the pathophysiological mechanisms of dystrophin deficiency will help develop therapies to improve musculoskeletal health. |
2023-06-01 |
2023-08-14 |
mouse |